How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Thermal Ablation Devices Market
- By Technology Type: Radiofrequency Ablation (RFA), Microwave Ablation (MWA), Cryoablation, High-Intensity Focused Ultrasound (HIFU), Laser Ablation
- By Application: Liver Tumors, Lung Tumors, Kidney Tumors, Bone Metastases, Cardiac Arrhythmias
- By End User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Cancer Treatment Centers
- By Procedure Guidance: Ultrasound-Guided Ablation, Computed Tomography (CT)-Guided Ablation, Magnetic Resonance Imaging (MRI)-Guided Ablation
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Radiofrequency Ablation (RFA) leads By Technology Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 17 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 279 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.165 →
- 11 Company Profiles 17 players: SWOT & benchmarking p.173 →
Full report · locked preview
Everything inside the Thermal Ablation Devices Market report
A complete, evidence-based study - 11 chapters and 117 sections covering market size, segmentation across 4 axes, regional analysis and 17 company profiles, forecast to 2033.
Segmentation covered
Technology Type 5
Application 5
End User 4
Procedure Guidance 3
Companies profiled
Medtronic
Boston Scientific Corporation
Johnson & Johnson (Biosense Webster)
AngioDynamics Inc.
Siemens Healthineers
Stryker Corporation
Becton
Dickinson and Company (BD)
Hologic Inc.
Olympus Corporation
Medtronic (Covidien)
Terumo Corporation
+5 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
17 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Medtronic
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Boston Scientific Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Johnson & Johnson (Biosense Webster)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →AngioDynamics Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Siemens Healthineers
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Stryker Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Becton
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Dickinson and Company (BD)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Hologic Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Olympus Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Medtronic (Covidien)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Terumo Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Neuwave Medical Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.227 →Johnson & Johnson (Ethicon)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →C.R. Bard
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Inc. (now part of BD)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Accuray Incorporated
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.250 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$7,475M by 2033 · 6.2% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Radiofrequency Ablation (RFA)46.3
- Microwave Ablation (MWA)17.0
- Cryoablation9.4
- High-Intensity Focused Ultrasound (HIFU)9.9
- Laser Ablation17.4
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,530M → $2,250M · 4.9%
Europe$1,066M → $1,749M · 6.4%
Asia Pacific$973.5M → $1,693M · 7.2%
Latin America$602.7M → $919.4M · 5.4%
Middle East and Africa$463.6M → $713.8M · 5.5%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →6.102026
6.132027
6.142028
6.142029
6.162030
6.162031
6.182032
6.202033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Medtronic15.1
- Boston Scientific Corporation20.5
- Johnson & Johnson (Biosense Webster)11.8
- AngioDynamics Inc.7.4
- Siemens Healthineers11.3
- Stryker Corporation5.9
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Technology Type23.5%
Application29.6%
End User11.8%
Procedure Guidance35.1%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America30.7
- Europe23.9
- Asia Pacific23.1
- Latin America12.5
- Middle East and Africa9.7
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Medtronic | 75 | 74 | 83 | 81 | 82 | 79 | 79 |
| Boston Scientific Corporation | 68 | 70 | 75 | 88 | 73 | 73 | 75 |
| Johnson & Johnson (Biosense Webster) | 73 | 71 | 71 | 83 | 87 | 64 | 75 |
| AngioDynamics Inc. | 70 | 78 | 70 | 77 | 58 | 59 | 69 |
| Siemens Healthineers | 68 | 65 | 72 | 62 | 68 | 68 | 67 |
| Stryker Corporation | 67 | 46 | 54 | 61 | 57 | 56 | 57 |
| Becton | 53 | 60 | 65 | 53 | 56 | 57 | 57 |
| Dickinson and Company (BD) | 35 | 35 | 60 | 47 | 42 | 40 | 43 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Medtronic
- Boston Scientific Corporation
- Johnson & Johnson (Biosense Webster)
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Medtronic | ✓ | − | ◐ | ◐ | ◐ | ◐ |
| Boston Scientific Corporation | ◐ | ◐ | ◐ | ✓ | ✓ | ✓ |
| Johnson & Johnson (Biosense Webster) | ◐ | ◐ | ✓ | ◐ | ✓ | − |
| AngioDynamics Inc. | ◐ | ◐ | ◐ | ◐ | ◐ | − |
| Siemens Healthineers | ◐ | ◐ | ◐ | ◐ | − | − |
| Stryker Corporation | ✓ | − | − | ◐ | − | ◐ |
| Becton | − | − | ◐ | ◐ | ◐ | ◐ |
| Dickinson and Company (BD) | − | − | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Medtronic79
2Boston Scientific Corporation75
3Johnson & Johnson (Biosense Webster)75
4AngioDynamics Inc.69
5Siemens Healthineers67
6Stryker Corporation57
7Becton57
8Dickinson and Company (BD)43
Competitive tiers
§8.4 · p.172 →Leader1
Set the pace on share, breadth and innovation.
Medtronic
Challenger4
Strong scale, closing on the leaders.
Boston Scientific CorporationJohnson & Johnson (Biosense Webster)AngioDynamics Inc.Siemens Healthineers
Contender2
Focused players with pockets of strength.
Stryker CorporationBecton
Niche1
Specialists in a single segment or region.
Dickinson and Company (BD)
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Technology Type in North America, then scale across Thermal Ablation Devices Market — a $402M beachhead inside a $7.71B market.
Beachhead (SOM)$402Mobtainable near-term
Serviceable (SAM)$2.84Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale3 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion90 fit
Radiofrequency Ablation (RFA)
Best fit — highest urgency & budget in Technology Type.
Economic buyer77 fit
Microwave Ablation (MWA)
Strong fit — clear ROI and a fast path to value.
End user69 fit
Cryoablation
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Technology Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Application & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales44%
Partner / channel29%
Digital / self-serve20%
Marketplaces6%
Positioning & messaging
§GTM 2 · p.194 →For Technology Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Thermal Ablation Devices Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified45%
Sales qualified21%
Evaluation13%
Closed-won8%
$11.0KCAC
$52KLTV
4.7:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Thermal Ablation Devices Market is a durable-growth opportunity — $5.78B by 2033, compounding at 7.7%.
TAM · 2025$3.19Btoday
TAM · 2033$5.78Bforecast
CAGR7.7%2027–2033
Cumulative$39.4Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$5.78BTotal addressable market
SAM$2.06BServiceable available market
SOM$393MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →7.7% CAGR
Demand compounds through 2033, outpacing GDP across Technology Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Technology Type moving from early to mainstream — durable secular demand.
Consolidation upside
17+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$5.78BLarge & growingTAM by 2033 at 7.7% CAGR
$2.06BServiceable nowreachable with today’s model
$393MBeachhead winobtainable near-term share
17+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$4.51BBear5.0% CAGR
$5.78BBase7.7% CAGR
$7.40BBull10.2% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Application optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Thermal Ablation Devices Market — a $9.17B market by 2033. Plan: grow share from 7.9% to 12.8%.
Market size · 2033$9.17Btotal addressable
Market CAGR6.7%2027–2033
Target share12.8%from 7.9% today
Revenue ambition$1.17Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.9% | 12.8% | On track |
| Revenue | $712M | $1.17B | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | At risk |
| Gross margin | 36.5% | 40.5% | On track |
| Customer retention | 90.3% | 94.7% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Technology Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Application capability
A defensible second engine — invest in Application to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Technology Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Application
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $175M capacity & capability investment
- Greenlight bolt-on M&A in Application
- Authorise North America expansion plan
- Fund R&D program for Technology Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossOn track
- Input-cost & supply riskAt risk
- Regulatory / policy changeBehind
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Thermal Ablation Devices Market conversation — a $4.23B market you can size, segment and defend in minutes.
Market size · 2033$4.23Btotal opportunity
Growth5.7%CAGR to 2033
Addressable buyers1,021+accounts in scope
Typical ROI4.4×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Technology Type
Goal Grow share in Technology Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.4×return on cost, year one
< 3 mopayback period
$47K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
17+players profiled in this market
Coverage includes
MedtronicBoston Scientific CorporationJohnson & Johnson (Biosense Webster)AngioDynamics Inc.Siemens HealthineersStryker CorporationBectonDickinson and Company (BD)+9 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Thermal Ablation Devices Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Thermal Ablation Devices Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Ventilator Test Systems Market
Market size, share, segmentation and regional forecast.
$5.9B market · 2025 base year
View reportDental Milling Machine Market
Market size, share, segmentation and regional forecast.
$3.7B market · 2025 base year
View reportArrhythmia Monitoring Devices Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportKidney Stone Extraction Balloon Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportSpinal Implants and Devices Market
Market size, share, segmentation and regional forecast.
$5.8B market · 2025 base year
View reportAnimal Brucella Antibody ELISA Kits Market
Market size, share, segmentation and regional forecast.
$5.1B market · 2025 base year
View reportCardiac Output Monitoring Market
Market size, share, segmentation and regional forecast.
$6.0B market · 2025 base year
View reportSmart Home Medical System Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportECG (Electrocardiogram) Device Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportFluid Management Systems Market
Market size, share, segmentation and regional forecast.
$4.3B market · 2025 base year
View reportObesity Treating Neuromodulation System Market
Market size, share, segmentation and regional forecast.
$2.6B market · 2025 base year
View reportOral X-Ray Machines Market
Market size, share, segmentation and regional forecast.
$1.0B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.